National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Access to Care (3)
- Adverse Drug Events (ADE) (48)
- Adverse Events (140)
- Alcohol Use (2)
- Ambulatory Care and Surgery (9)
- Antibiotics (14)
- Antimicrobial Stewardship (4)
- Anxiety (1)
- Arthritis (16)
- Asthma (8)
- Back Health and Pain (1)
- Behavioral Health (31)
- Blood Clots (19)
- Blood Pressure (13)
- Blood Thinners (11)
- Brain Injury (7)
- Cancer (68)
- Cancer: Breast Cancer (19)
- Cancer: Cervical Cancer (1)
- Cancer: Colorectal Cancer (8)
- Cancer: Lung Cancer (4)
- Cancer: Ovarian Cancer (2)
- Cancer: Prostate Cancer (5)
- Cardiovascular Conditions (124)
- Caregiving (3)
- Care Management (4)
- Case Study (10)
- Catheter-Associated Urinary Tract Infection (CAUTI) (2)
- Centers for Education and Research on Therapeutics (CERTs) (2)
- Central Line-Associated Bloodstream Infections (CLABSI) (7)
- Children/Adolescents (75)
- Chronic Conditions (36)
- Clinical Decision Support (CDS) (12)
- Clinician-Patient Communication (6)
- Clostridium difficile Infections (8)
- Colonoscopy (5)
- Communication (7)
- Community-Acquired Infections (11)
- Community-Based Practice (2)
- Comparative Effectiveness (23)
- Complementary and Alternative Medicine (1)
- COVID-19 (23)
- Critical Care (7)
- Cultural Competence (1)
- Data (4)
- Decision Making (24)
- Dementia (7)
- Dental and Oral Health (1)
- Depression (20)
- Diabetes (40)
- Diagnostic Safety and Quality (21)
- Dialysis (2)
- Digestive Disease and Health (12)
- Disparities (17)
- Domestic Violence (2)
- Education (1)
- Education: Continuing Medical Education (1)
- Education: Patient and Caregiver (8)
- Elderly (81)
- Electronic Health Records (EHRs) (32)
- Electronic Prescribing (E-Prescribing) (2)
- Emergency Department (34)
- Emergency Medical Services (EMS) (4)
- Emergency Preparedness (1)
- Evidence-Based Practice (32)
- Eye Disease and Health (5)
- Falls (24)
- Family Health and History (7)
- Genetics (11)
- Guidelines (9)
- Healthcare-Associated Infections (HAIs) (50)
- Healthcare Cost and Utilization Project (HCUP) (29)
- Healthcare Costs (10)
- Healthcare Delivery (3)
- Healthcare Utilization (9)
- Health Information Technology (HIT) (40)
- Health Insurance (3)
- Health Literacy (3)
- Health Promotion (3)
- Health Services Research (HSR) (2)
- Health Status (10)
- Health Systems (4)
- Heart Disease and Health (73)
- Hepatitis (5)
- Home Healthcare (10)
- Hospital Discharge (13)
- Hospitalization (54)
- Hospital Readmissions (47)
- Hospitals (27)
- Human Immunodeficiency Virus (HIV) (25)
- Imaging (7)
- Implementation (4)
- Infectious Diseases (20)
- Influenza (1)
- Injuries and Wounds (42)
- Inpatient Care (5)
- Intensive Care Unit (ICU) (11)
- Kidney Disease and Health (21)
- Labor and Delivery (15)
- Learning Health Systems (1)
- Lifestyle Changes (16)
- Long-Term Care (9)
- Low-Income (4)
- Maternal Care (8)
- Medicaid (6)
- Medical Devices (4)
- Medical Errors (10)
- Medical Expenditure Panel Survey (MEPS) (6)
- Medical Liability (3)
- Medicare (11)
- Medication (111)
- Medication: Safety (20)
- Men's Health (4)
- Methicillin-Resistant Staphylococcus aureus (MRSA) (6)
- Mortality (59)
- Neonatal Intensive Care Unit (NICU) (2)
- Neurological Disorders (17)
- Newborns/Infants (23)
- Nursing (3)
- Nursing Homes (14)
- Nutrition (11)
- Obesity (27)
- Obesity: Weight Management (5)
- Opioids (15)
- Organizational Change (1)
- Orthopedics (6)
- Osteoporosis (5)
- Outcomes (58)
- Pain (3)
- Palliative Care (3)
- Patient-Centered Healthcare (8)
- Patient-Centered Outcomes Research (54)
- Patient Adherence/Compliance (2)
- Patient and Family Engagement (1)
- Patient Safety (100)
- Patient Self-Management (1)
- Payment (2)
- Pneumonia (6)
- Policy (4)
- Practice Patterns (5)
- Pregnancy (29)
- Prevention (52)
- Primary Care (13)
- Provider (6)
- Provider: Clinician (2)
- Provider: Health Personnel (2)
- Provider: Nurse (3)
- Provider: Pharmacist (2)
- Provider Performance (3)
- Public Health (11)
- Quality Improvement (12)
- Quality Indicators (QIs) (4)
- Quality Measures (4)
- Quality of Care (17)
- Quality of Life (3)
- Racial and Ethnic Minorities (44)
- Registries (9)
- Rehabilitation (2)
- Research Methodologies (10)
- Respiratory Conditions (32)
- (-) Risk (756)
- Rural Health (3)
- Screening (19)
- Sepsis (16)
- Sex Factors (6)
- Sexual Health (9)
- Skin Conditions (11)
- Sleep Problems (6)
- Social Determinants of Health (32)
- Social Media (2)
- Stress (4)
- Stroke (27)
- Substance Abuse (16)
- Surgery (120)
- Telehealth (1)
- Tobacco Use (9)
- Tools & Toolkits (3)
- Transitions of Care (5)
- Transplantation (14)
- Trauma (11)
- Treatments (5)
- U.S. Preventive Services Task Force (USPSTF) (19)
- Uninsured (1)
- Urban Health (8)
- Urinary Tract Infection (UTI) (3)
- Vaccination (4)
- Vulnerable Populations (5)
- Web-Based (1)
- Women (44)
- Workforce (1)
- Young Adults (9)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
126 to 150 of 756 Research Studies DisplayedMian HS, Fiala MA, Sanchez L
Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the "real world."
Researchers investigated the rate of renal failure and associated risk factors in real-world populations of patients with multiple myeloma taking carfilzomib. Using Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data, they found that renal failure developed in 22% of patients during the study period. The median time to development of renal failure from first carfilzomib administration was 1.6 months. Increasing age, pre-existing heart failure, and pre-existing chronic kidney disease were associated with a higher risk of developing renal failure. As their study could not determine the exact cause and mechanism of renal failure, they recommended future studies to further understand this cause among patients on carfilzomib and to devise strategies to mitigate the risk.
AHRQ-funded; HS019455.
Citation: Mian HS, Fiala MA, Sanchez L .
Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the "real world."
Ann Hematol 2021 May;100(5):1261-66. doi: 10.1007/s00277-021-04420-3..
Keywords: Cancer, Kidney Disease and Health, Medication, Adverse Drug Events (ADE), Adverse Events, Risk
Javalkar K, Robson VK, Gaffney L
Socioeconomic and racial and/or ethnic disparities in multisystem inflammatory syndrome.
Researchers characterized the socioeconomic and racial and/or ethnic disparities impacting the diagnosis and outcomes of multisystem inflammatory syndrome in children (MIS-C). They found that lower socioeconomic status or higher social vulnerability index, Hispanic ethnicity, and Black race independently increased risk for MIS-C. They recommended additional studies to target interventions to improve health equity for children.
AHRQ-funded; HS000063.
Citation: Javalkar K, Robson VK, Gaffney L .
Socioeconomic and racial and/or ethnic disparities in multisystem inflammatory syndrome.
Pediatrics 2021 May;147(5). doi: 10.1542/peds.2020-039933..
Keywords: Children/Adolescents, Social Determinants of Health, Disparities, Racial and Ethnic Minorities, Risk
Baillargeon J, Polychronopoulou E, Kuo YF
The impact of substance use disorder on COVID-19 outcomes.
The goal of this study was to examine the impact of substance use disorder on the risk of hospitalization, complications, and mortality among adult patients diagnosed as having COVID-19. Using data from the TriNetX Research Network database, primary analysis showed that substance use disorder was associated with an increased risk of hospitalization, ventilator use, and mortality. These findings suggest that COVID-19 patients with substance use disorders are at increased risk for adverse outcomes.
AHRQ-funded; HS026133.
Citation: Baillargeon J, Polychronopoulou E, Kuo YF .
The impact of substance use disorder on COVID-19 outcomes.
Psychiatr Serv 2021 May;72(5):578-81. doi: 10.1176/appi.ps.202000534..
Keywords: COVID-19, Substance Abuse, Hospitalization, Mortality, Risk
Daymont C, Balamuth F, Scott HF
Elevated heart rate and risk of revisit with admission in pediatric emergency patients.
This study examines whether emergency department (ED) heart rate (HR) values can identify children at elevated risk of ED revisit with admission. The authors performed a retrospective cohort study of children ages 0-18 years discharged from a tertiary-care pediatric ED from 2013 to 2014. They created percentile curves for the last recorded HR for age using data from calendar year 2013 and used receiver operating characteristic (ROC) curves to characterize the performance of the percentiles for predicting ED revisit with admission within 72 hours. They evaluated 183,433 eligible ED visits and found that the last recorded HR for age had poor discrimination for predicting revisit with admission.
AHRQ-funded; HS023827.
Citation: Daymont C, Balamuth F, Scott HF .
Elevated heart rate and risk of revisit with admission in pediatric emergency patients.
Pediatr Emerg Care 2021 Apr;37(4):e185-e91. doi: 10.1097/pec.0000000000001552..
Keywords: Children/Adolescents, Emergency Department, Risk, Hospitalization
O'Donoghue A, Dechen T, O'Donoghue A, Dechen T, Pavlova W W
Reopening businesses and risk of COVID-19 transmission.
In this paper, the authors used anonymized cell-phone data to quantify the potential risk of COVID-19 transmission in business establishments by building a Business Risk Index that measures transmission risk over time. They used two metrics, visits per square foot and the average duration of visits from January 2020 to June 2020. They found that an increase in a county's average Business Risk Index is associated with an increase in positive COVID-19 cases in 1 week. Their risk index provides a way for policymakers and hospital decision-makers to monitor the potential risk of COVID-19 transmission from businesses based on the frequency and density of visits to businesses.
AHRQ-funded; HS024288.
Citation: O'Donoghue A, Dechen T, O'Donoghue A, Dechen T, Pavlova W W .
Reopening businesses and risk of COVID-19 transmission.
NPJ Digit Med 2021 Mar 16;4(1):51. doi: 10.1038/s41746-021-00420-9..
Keywords: COVID-19, Community-Acquired Infections, Public Health, Risk
Richardson L, Parker EO, Zhou C
Electronic health risk behavior screening with integrated feedback among adolescents in primary care: randomized controlled trial.
Health risk behaviors are the most common sources of morbidity among adolescents. Adolescent health guidelines (Guidelines for Preventive Services by the AMA and Bright Futures by the Maternal Child Health Bureau) recommend screening and counseling, but the implementation is inconsistent. This study aimed to test the efficacy of electronic risk behavior screening with integrated patient-facing feedback on the delivery of adolescent-reported clinician counseling and risk behaviors over time.
AHRQ-funded; HS023383.
Citation: Richardson L, Parker EO, Zhou C .
Electronic health risk behavior screening with integrated feedback among adolescents in primary care: randomized controlled trial.
J Med Internet Res 2021 Mar 12;23(3):e24135. doi: 10.2196/24135..
Keywords: Children/Adolescents, Primary Care, Risk, Screening
Kostick KM, Blumenthal-Barby JS
Avoiding "toxic knowledge": the importance of framing personalized risk information in clinical decision-making.
In this article, the authors discuss personalized risk information in clinical decision making, concluding that the framing of this information’s intended purpose at the patient level should be tailored to the decision-making context as a patient perceives it, which may vary from patient to patient.
AHRQ-funded; HS027784.
Citation: Kostick KM, Blumenthal-Barby JS .
Avoiding "toxic knowledge": the importance of framing personalized risk information in clinical decision-making.
Per Med 2021 Mar;18(2):91-95. doi: 10.2217/pme-2020-0174..
Keywords: Clinical Decision Support (CDS), Decision Making, Risk, Clinician-Patient Communication, Communication
Ye S, Hiura G, Fleck E
Hospital readmissions after implementation of a discharge care program for patients with COVID-19 illness.
The surge of coronavirus 2019 (COVID-19) hospitalizations in New York City required rapid discharges to maintain hospital capacity. The objective of this study was to determine whether lenient provisional discharge guidelines with remote monitoring after discharge resulted in safe discharges home for patients hospitalized with COVID-19 illness. The investigators found that lenient discharge criteria in conjunction with remote monitoring after discharge were associated with a rate of early readmissions after COVID-related hospitalizations that was comparable to the rate of readmissions after other reasons for hospitalization before the COVID pandemic.
AHRQ-funded; HS024262; HS025198.
Citation: Ye S, Hiura G, Fleck E .
Hospital readmissions after implementation of a discharge care program for patients with COVID-19 illness.
J Gen Intern Med 2021 Mar;36(3):722-29. doi: 10.1007/s11606-020-06340-w..
Keywords: COVID-19, Hospital Discharge, Hospital Readmissions, Hospitals, Public Health, Hospitalization, Risk
Shah SC, Zhu X, Dai Q
Magnesium intake is associated with a reduced risk of incident liver cancer, based on an analysis of the NIH-American Association of Retired Persons (NIH-AARP) Diet and Health Study prospective cohort.
Liver cancer incidence and mortality are escalating globally. Magnesium intake has been studied extensively in nonmalignant liver pathology, but the association between dietary intake of magnesium and primary liver malignancy has not been previously evaluated. In this study, investigators aimed to determine the association between total magnesium intake and primary liver cancer risk. The investigators concluded that based on their prospective cohort analysis, magnesium intake was associated with a lower risk of primary liver cancer, which was more pronounced among moderate and heavy alcohol users.
AHRQ-funded; HS026395.
Citation: Shah SC, Zhu X, Dai Q .
Magnesium intake is associated with a reduced risk of incident liver cancer, based on an analysis of the NIH-American Association of Retired Persons (NIH-AARP) Diet and Health Study prospective cohort.
Am J Clin Nutr 2021 Mar 11;113(3):630-38. doi: 10.1093/ajcn/nqaa326..
Keywords: Cancer, Risk, Digestive Disease and Health, Prevention
Kuperberg M, Katz D, Greenebaum SLA
Psychotic symptoms during bipolar depressive episodes and suicidal ideation.
Researchers examined the relationship between psychotic symptoms during a depressive episode and suicidal ideation in bipolar patients. Psychotic symptoms in adult, depressed outpatients with bipolar disorder (BD) in a comparative effectiveness study of quetiapine versus lithium were assessed via Bipolar Inventory of Signs and Symptoms Scale (BISS); depressive episodes were assessed via Mini-International Neuropsychiatric Interview (MINI). The researchers found that, while a small proportion of bipolar disorder outpatients had current symptoms of psychosis during their depressive episode, those who did were more likely to endorse active suicidal thoughts, including suicide methods and plans.
AHRQ-funded; HS019371.
Citation: Kuperberg M, Katz D, Greenebaum SLA .
Psychotic symptoms during bipolar depressive episodes and suicidal ideation.
J Affect Disord 2021 Mar 1;282:1241-46. doi: 10.1016/j.jad.2020.12.184..
Keywords: Depression, Behavioral Health, Risk
Maloney MH, Payne SR, Herrin J
Risk of systemic adverse events after intravitreal bevacizumab, ranibizumab, and aflibercept in routine clinical practice.
Intravitreal anti-vascular endothelial growth factor (VEGF) pharmacotherapy plays a central role in the management of neovascular age-related macular degeneration (nAMD), diabetic retinal disease (DRD), and retinal venous occlusive disease (RVO). The goal of this study was to compare the systemic safety of intravitreal bevacizumab, ranibizumab, and aflibercept in real-world practice. The investigators observed no differences in the risk of acute MI, CVD, major bleeding, or all-cause hospitalization after treatment initiation with intravitreal bevacizumab, ranibizumab, or aflibercept during routine clinical practice.
AHRQ-funded; HS024075; HS025164; HS025402; HS025517; HS026379.
Citation: Maloney MH, Payne SR, Herrin J .
Risk of systemic adverse events after intravitreal bevacizumab, ranibizumab, and aflibercept in routine clinical practice.
Ophthalmology 2021 Mar;128(3):417-24. doi: 10.1016/j.ophtha.2020.07.062..
Keywords: Eye Disease and Health, Medication, Risk, Adverse Drug Events (ADE), Adverse Events
Osterman CK, Triglianos T, Winzelberg GS
Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic.
The authors sought to risk-stratify hematology/oncology patients using general medicine and cancer-specific methods to identify those at high risk for acute care utilization, to measure the correlation between two risk stratification methods, and to perform a telephone-based needs assessment with intervention for high-risk patients. They concluded that there is a high burden of unmet medical and psychosocial needs in hematology/oncology patients during the COVID-19 pandemic, and they recommended a telephone-based outreach program for the identification of and intervention for these needs.
AHRQ-funded; H2000032.
Citation: Osterman CK, Triglianos T, Winzelberg GS .
Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic.
Support Care Cancer 2021 Mar;29(3):1161-64. doi: 10.1007/s00520-020-05744-y..
Keywords: COVID-19, Cancer, Risk
Miller AC, Arakkal AT, Koeneman S
Incidence, duration and risk factors associated with delayed and missed diagnostic opportunities related to tuberculosis: a population-based longitudinal study.
Missed opportunities to diagnose tuberculosis are costly to patients and society. In this retrospective cohort study, the investigators (1) estimated the frequency and duration of diagnostic delays among patients with active pulmonary tuberculosis and (2) determined the risk factors for experiencing a diagnostic delay. The investigators found that many patients with tuberculosis experience multiple missed diagnostic opportunities prior to diagnosis.
AHRQ-funded; HS027375.
Citation: Miller AC, Arakkal AT, Koeneman S .
Incidence, duration and risk factors associated with delayed and missed diagnostic opportunities related to tuberculosis: a population-based longitudinal study.
BMJ Open 2021 Feb 18;11(2):e045605. doi: 10.1136/bmjopen-2020-045605..
Keywords: Respiratory Conditions, Diagnostic Safety and Quality, Risk
Dowding D, Russell D, McDonald MV
"A catalyst for action": factors for implementing clinical risk prediction models of infection in home care settings.
This study looked at how a clinical risk prediction model for identifying patients at risk of infection is perceived by home care nurses. It was a qualitative study using semi-structured interviews with 50 home care nurses. The interviews were audio-taped and transcribed with data evaluation using thematic analysis. Findings indicated that the nurses would find a clinical risk prediction model useful, as long as it provided both context around the reasons why a patient was deemed to be high risk and provided some guidance for action.
AHRQ-funded; HS024723.
Citation: Dowding D, Russell D, McDonald MV .
"A catalyst for action": factors for implementing clinical risk prediction models of infection in home care settings.
J Am Med Inform Assoc 2021 Feb 15;28(2):334-41. doi: 10.1093/jamia/ocaa267..
Keywords: Home Healthcare, Nursing, Risk, Healthcare-Associated Infections (HAIs), Prevention, Provider: Nurse, Provider
Schlick CJR, Yuce TK, Yang AD
A postdischarge venous thromboembolism risk calculator for inflammatory bowel disease surgery.
Guidelines recommend extended chemoprophylaxis for venous thromboembolism in high-risk patients having operations for inflammatory bowel disease. Quantifying patients' risk of venous thromboembolism, however, remains challenging. In this study, the investigators sought (1) to identify factors associated with postdischarge venous thromboembolism in patients undergoing colorectal resection for inflammatory bowel disease and (2) to develop a postdischarge venous thromboembolism risk calculator to guide prescribing of extended chemoprophylaxis.
AHRQ-funded; HS024516; HS000078; HS026385.
Citation: Schlick CJR, Yuce TK, Yang AD .
A postdischarge venous thromboembolism risk calculator for inflammatory bowel disease surgery.
Surgery 2021 Feb;169(2):240-47. doi: 10.1016/j.surg.2020.09.006..
Keywords: Blood Clots, Adverse Events, Patient Safety, Surgery, Risk
Tuzzio L, O'Meara ES, Holden E
Barriers to implementing cardiovascular risk calculation in primary care: alignment with the consolidated framework for implementation research.
The uptake of cardiovascular disease risk calculators in primary care has been slow despite the recommendation in national cardiovascular disease prevention guidelines. Identifying the barriers to the implementation of cardiovascular disease risk calculators is essential for promoting their adoption. In this study, the authors qualitatively analyzed structured physician educator notes written during an outreach education intervention with 44 small- and medium-sized primary care clinics that participated in the Agency for Healthcare Research and Quality‒funded EvidenceNOW Healthy Hearts Northwest trial.
AHRQ-funded; HS023908.
Citation: Tuzzio L, O'Meara ES, Holden E .
Barriers to implementing cardiovascular risk calculation in primary care: alignment with the consolidated framework for implementation research.
Am J Prev Med 2021 Feb;60(2):250-57. doi: 10.1016/j.amepre.2020.07.027..
Keywords: Heart Disease and Health, Cardiovascular Conditions, Primary Care, Risk, Evidence-Based Practice, Implementation
Turi KN, Gebretsadik T, Ding T
Dose, timing, and spectrum of prenatal antibiotic exposure and risk of childhood asthma.
The potential for prenatal antibiotic exposure to influence asthma risk is not clear. The investigators aimed to determine the effect of timing, dose, and spectrum of prenatal antibiotic exposure on the risk of childhood asthma. The investigators concluded that increased cumulative dose, early pregnancy first course, and broad-spectrum antibiotic exposure were associated with childhood asthma risk.
AHRQ-funded; HS026395; HS018454.
Citation: Turi KN, Gebretsadik T, Ding T .
Dose, timing, and spectrum of prenatal antibiotic exposure and risk of childhood asthma.
Clin Infect Dis 2021 Feb 1;72(3):455-62. doi: 10.1093/cid/ciaa085.
.
.
Keywords: Children/Adolescents, Asthma, Respiratory Conditions, Antibiotics, Medication, Risk
Kadri SS, Lai YL, Warner S
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.
Researchers sought to establish the population-level burden, predictors, and mortality risk of in-vitro susceptibility-discordant empirical antibiotic therapy among patients with bloodstream infections. They found that approximately one in five patients with bloodstream infections in US hospitals received discordant empirical antibiotic therapy, receipt of which was closely associated with infection with antibiotic-resistant pathogens. Receiving discordant empirical antibiotic therapy was associated with increased odds of mortality overall, even in patients without sepsis. They concluded that early identification of bloodstream pathogens and resistance will probably improve population-level outcomes.
AHRQ-funded.
Citation: Kadri SS, Lai YL, Warner S .
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.
Lancet Infect Dis 2021 Feb;21(2):241-51. doi: 10.1016/s1473-3099(20)30477-1..
Keywords: Antibiotics, Medication, Sepsis, Antimicrobial Stewardship, Mortality, Risk
Horton DB, Xie F, Chen L
Oral glucocorticoids and incident treatment of diabetes mellitus, hypertension, and venous thromboembolism in children.
The purpose of this study was to quantify rates of incident treatment for diabetes mellitus, hypertension, and venous thromboembolism (VTE) associated with oral glucocorticoid exposure in children aged 1-18 years. Participants were identified using US Medicaid claims data and included more than 930,000 children diagnosed with autoimmune diseases or a nonimmune comparator condition. Findings showed strong dose-dependent relationships between current glucocorticoid exposure and all outcomes, suggesting strong relative risks, but low absolute risks, of newly-treated VTE, diabetes, and especially hypertension in children taking high-dose oral glucocorticoids.
AHRQ-funded; HS021110.
Citation: Horton DB, Xie F, Chen L .
Oral glucocorticoids and incident treatment of diabetes mellitus, hypertension, and venous thromboembolism in children.
Am J Epidemiol 2021 Feb 1;190(3):403-12. doi: 10.1093/aje/kwaa197..
Keywords: Children/Adolescents, Diabetes, Chronic Conditions, Blood Clots, Medication: Safety, Medication, Adverse Drug Events (ADE), Adverse Events, Risk, Patient Safety, Blood Pressure
Braet DJ, Smith JB, Bath J
Risk factors associated with 30-day hospital readmission after carotid endarterectomy.
This study looked at the risk factors associated with 30-day hospital readmission after carotid endarterectomy. Patients in the Cerner Health Facts® database were selected using ICD-9-CM procedure codes. A total of 5257 patients were identified who had undergone elective carotid endarterectomy. Readmission was associated with end-stage renal disease, hemorrhage or hematoma, procedural complications, use of bronchodilators, electrolyte abnormalities, and hypokalemia less than 3.7 mEq/L. Although protamine reduces the risk of bleeding complications, only 40% of patients received that medication.
AHRQ-funded; HS022140.
Citation: Braet DJ, Smith JB, Bath J .
Risk factors associated with 30-day hospital readmission after carotid endarterectomy.
Vascular 2021 Feb;29(1):61-68. doi: 10.1177/1708538120937955..
Keywords: Hospital Readmissions, Surgery, Cardiovascular Conditions, Risk, Adverse Events
Sabbagh SE, Neely J, Chow A
Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America.
Pneumocystis jirovecii pneumonia (PJP) is associated with significant morbidity and mortality in adult myositis patients; however, there are few studies examining PJP in juvenile myositis [juvenile idiopathic inflammatory myopathy (JIIM)]. The purpose of this study was to determine the risk factors and clinical phenotypes associated with PJP in JIIM. The investigators concluded that having PJP was associated with more immunosuppressive therapy, anti-MDA5 autoantibodies, Asian race and certain clinical features, including digital infarcts, cutaneous ulcerations and interstitial lung disease.
AHRQ-funded; HS000063.
Citation: Sabbagh SE, Neely J, Chow A .
Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America.
Rheumatology 2021 Feb;60(2):829-36. doi: 10.1093/rheumatology/keaa436..
Keywords: Children/Adolescents, Pneumonia, Respiratory Conditions, Risk
Li K, Ferguson T, Embil J
Risk of kidney failure, death, and cardiovascular events after lower limb complications in patients with CKD.
Investigators sought to determine how interim lower limb complications modify the subsequent risk of progression to kidney failure, all-cause mortality before kidney failure, and cardiovascular events in a cohort of patients with chronic kidney disease (CKD) stages G3 to G5. Patient-level data obtained from several administrative databases from Manitoba, Canada, were analyzed. They found that interim lower limb complications were associated with an increased risk of kidney failure, all-cause mortality before kidney failure, and cardiovascular-related hospitalization. They stated that clinical trials of screening and treatment strategies for patients with CKD at risk for lower limb complications may help determine optimal strategies to manage this risk.
AHRQ-funded; HS018574.
Citation: Li K, Ferguson T, Embil J .
Risk of kidney failure, death, and cardiovascular events after lower limb complications in patients with CKD.
Kidney Int Rep 2021 Feb;6(2):381-88. doi: 10.1016/j.ekir.2020.11.010..
Keywords: Kidney Disease and Health, Cardiovascular Conditions, Chronic Conditions, Risk, Adverse Events, Mortality, Outcomes
Abraham J, Galanter WL, Touchette D
Risk factors associated with medication ordering errors.
This study’s goal was to collect data on “voided” orders in computerized order entry systems for medication to 1) identify the nature and characteristics of medication ordering errors; 2) investigate the risk factors associated with these errors and; 3) explore potential strategies to mitigate these risk factors. Data was collected using clinician interviews and surveys within 24 hours of the voided order and using chart reviews. During the 16-month study period 1074 medication orders were voided, with 842 being true medication errors. A total of 22% reached the patient, with at least a single administration, but without causing patient harm. Interviews were conducted on 355 voided orders (33%). Errors were associated with multiple factors not just a single risk factor. The causal contributors included a combination of technological-, cognitive-, environment-, social-, and organization-level factors.
AHRQ-funded; HS025443.
Citation: Abraham J, Galanter WL, Touchette D .
Risk factors associated with medication ordering errors.
J Am Med Inform Assoc 2021 Jan 15;28(1):86-94. doi: 10.1093/jamia/ocaa264..
Keywords: Medication: Safety, Electronic Prescribing (E-Prescribing), Medication: Safety, Medication, Medical Errors, Adverse Drug Events (ADE), Adverse Events, Risk, Health Information Technology (HIT), Patient Safety
Berger BO, Wolfson C, Reid LD
AHRQ Author: Reid LD
Adverse birth outcomes among women of advanced maternal age with and without health conditions in Maryland.
This study examined the association between advanced maternal age (AMA) and adverse birth outcomes among women with and without preexisting and pregnancy-related health conditions. Data for singleton births from the population-based Maryland Pregnancy Risk Assessment Monitoring System 2004-2015 were used to compare women aged 20-34 years and 35 years and older. Findings indicated that AMA is associated with adverse birth outcomes among women with and without health conditions compared with younger women with similar health status. Recommendations included improved screening and management of health conditions during pregnancy for older women, regardless of parity.
AHRQ-authored.
Citation: Berger BO, Wolfson C, Reid LD .
Adverse birth outcomes among women of advanced maternal age with and without health conditions in Maryland.
Womens Health Issues 2021 Jan-Feb;31(1):40-48. doi: 10.1016/j.whi.2020.08.008..
Keywords: Pregnancy, Newborns/Infants, Outcomes, Women, Risk
Rodriguez SA, Higashi RT, Betts AC
Anal cancer and anal cancer screening knowledge, attitudes, and perceived risk among women living with HIV.
The aims of this study were (1) to describe anal cancer knowledge, perceived risk, screening barriers, and acceptability of sample self-collection among women living with HIV (WLWH) at an integrated safety-net system and (2) to describe differences in demographic and psychosocial variables among a subsample of WLWH with a history of abnormal cervical cytology results versus those with normal results. The investigators concluded that this study highlighted a gap in knowledge and awareness among WLWH regarding their heightened risk for anal cancer.
AHRQ-funded; HS022418.
Citation: Rodriguez SA, Higashi RT, Betts AC .
Anal cancer and anal cancer screening knowledge, attitudes, and perceived risk among women living with HIV.
J Low Genit Tract Dis 2021 Jan;25(1):43-47. doi: 10.1097/lgt.0000000000000578..
Keywords: Cancer, Screening, Human Immunodeficiency Virus (HIV), Risk, Women